{"id":"W2804131537","doi":"10.1111/bjd.16798","title":"Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Plaque psoriasis; Psoriasis; Open label; Dermatology; Term (time); Extension (predicate logic); Internal medicine; Adverse effect; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004387514,0.0007633421,0.00165516,0.0003216334,0.0004931197,0.0008413815,0.0004158122,0.00113317,0.002368286],"category_scores_gemma":[0.002044027,0.0003107097,0.001722098,0.0004214867,0.0004507437,0.0007151357,0.0003454155,0.002096251,0.0005956026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005450724,"about_ca_system_score_gemma":0.001033634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005004098,"about_ca_topic_score_gemma":0.0007993954,"domain_scores_codex":[0.9990483,0.0004367893,0.00007794928,0.0001286404,0.0001809565,0.0001273201],"domain_scores_gemma":[0.9974492,0.0004148856,0.0007662947,0.0002101398,0.0002683775,0.0008910249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7056684,0.05347497,0.06292713,0.001481512,0.003870724,0.0008648877,0.0005287724,0.0007319617,0.02090826,0.0001731794,0.004122408,0.1452478],"study_design_scores_gemma":[0.4650281,0.3441969,0.1799542,0.0001641516,0.001587368,0.001185951,0.000114877,0.001104817,0.001538069,0.0001911078,0.004874154,0.00006032412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934115,0.003491012,0.0002676865,0.0002265136,0.00005540843,0.0009809696,0.0006568948,0.00003191843,0.0008781187],"genre_scores_gemma":[0.9939398,0.001717885,0.0005754344,0.0005444665,0.0002854568,0.0009927701,0.001269773,0.000006753047,0.0006677441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004387514,"threshold_uncertainty_score":0.02320367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01980656841918901,"score_gpt":0.2715393643910453,"score_spread":0.2517327959718563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}